Brandy Fidler

2 days ago | informaconnect.com | Brandy Fidler

Compliance leadership in pharmaceuticals demands a delicate balance of technical expertise, strategic vision, and ethical stewardship, according to Peter J. Agnoletto, strategic business advisor, General Medicines U.S., at Sanofi. With over two decades of experience in multibillion-dollar international public companies, Agnoletto brings a wealth of knowledge from his roles, including his previous position as chief compliance officer and chief audit executive at Par Pharmaceuticals Companies.

2 weeks ago | informaconnect.com | Brandy Fidler

Amy Niles, the PAN Foundation’s chief mission officer, spoke exclusively with Access Insider about the current state of patient access, the barriers, the value of advocacy, and the need for action.

3 weeks ago | informaconnect.com | Brandy Fidler

In a recent fireside chat at the Rare Disease Summit in Philadelphia, Karin Hoelzer, senior director, patient advocacy at Biotechnology Innovation Organization (BIO), and Tricha Shivas chief strategy officer at the Foundation for Sarcoidosis Research explored the role patient advocacy groups play in accelerating and improving the development of therapies for rare diseases.

1 month ago | informaconnect.com | Brandy Fidler

Proactive compliance within reimbursement hubs, strategic navigation of data purchases, and medical and commercial interactions are among the rising trends in pharmaceutical compliance this year. In a recent webinar, “Pharmaceutical Compliance: Emerging Trends & Best Practices for 2025” webinar, hosted by the Pharmaceutical Compliance Congress in March, a group of compliance experts discussed the latest movements in the industry, offering insights and strategies to implement.

1 month ago | informaconnect.com | Brandy Fidler

Doreen Rice, director of patient assistance programs at AstraZeneca, shared her experience working strategically with legal and compliance teams at the recent Access USA conference.